The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis

Michael Nissen, Benedicte Delcoigne, Daniela Di Giuseppe, Lennart Jacobsson, Merete Lund Hetland, Adrian Ciurea, Lucie Nekvindova, Florenzo Iannone, Nurullah Akkoc, Tuulikki Sokka-Isler, Karen Minde Fagerli, Maria Jose Santos, Catalin Codreanu, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Irene Van der Horst-Bruinsma, Anne Gitte Loft, Burkhard Moeller, Herman MannFabrizio Conti, Gozde Yildirim Cetin, Heikki Relas, Brigitte Michelsen, Pedro Avila Ribeiro, Ruxandra Ionescu, Carlos Sanchez-Piedra, Matija Tomsic, Arni Jon Geirsson, Johan Askling, Bente Glintborg, Ulf Lindström

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalRheumatology
Volume61
Issue number12
Pages (from-to)4741-4751
Number of pages11
ISSN1462-0324
DOIs
Publication statusPublished - Dec 2022
MoE publication typeA1 Journal article-refereed

Fields of Science

  • spondylitis
  • ankylosing
  • MTX
  • SSZ
  • TNF inhibitors
  • epidemiology
  • MODIFYING ANTIRHEUMATIC DRUGS
  • ANKYLOSING-SPONDYLITIS
  • RHEUMATOID-ARTHRITIS
  • PSORIATIC-ARTHRITIS
  • TREATMENT RESPONSE
  • SPONDYLOARTHRITIS
  • COMEDICATION
  • INFLIXIMAB
  • METHOTREXATE
  • SURVIVAL
  • Epidemiology
  • Mtx
  • Spondylitis
  • Ankylosing
  • Ssz
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this